BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33977364)

  • 1. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.
    Yang Y; Fu S; Cao B; Hao K; Li Y; Huang J; Shi W; Duan C; Bai X; Tang K; Yang S; He X; Lu L
    Hepatol Int; 2021 Jun; 15(3):730-740. PubMed ID: 33977364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study.
    Chen X; Wang T; Ji Z; Luo J; Lv W; Wang H; Zhao Y; Duan C; Yu X; Li Q; Zhang J; Chen J; Zhang X; Huang M; Zhou S; Lu L; Huang M; Fu S
    Hepatol Int; 2023 Dec; 17(6):1545-1556. PubMed ID: 37531069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt.
    Yang Y; Liang X; Yang S; He X; Huang M; Shi W; Luo J; Duan C; Feng X; Fu S; Lu L
    Eur J Radiol; 2022 Sep; 154():110384. PubMed ID: 35667296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
    Li Y; He X; Pang H
    Turk J Gastroenterol; 2019 Aug; 30(8):702-707. PubMed ID: 31418414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Acad Radiol; 2024 May; 31(5):1849-1861. PubMed ID: 38007366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
    Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
    J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of Child-Pugh score and quantitative CT-based spleen volume could predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.
    Liu J; Zhou C; Wang Y; Yang C; Shi Q; Huang S; Chen Y; Li T; Xiong B
    Abdom Radiol (NY); 2021 Jul; 46(7):3464-3470. PubMed ID: 33660042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
    Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
    Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.
    Lin X; Gao F; Wu X; Cai W; Chen X; Huang Z
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):862-871. PubMed ID: 32541240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients.
    Yin X; Zhang F; Guo H; Peng C; Zhang W; Xiao J; Wang Y; Zou X; Zhang M; Zhuge Y
    Sci Rep; 2020 Jun; 10(1):9381. PubMed ID: 32523059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients.
    Liao Y; Zhang L; Wang JT; Yue ZD; Fan ZH; Wu YF; Zhang Y; Dong CB; Wang XQ; Cui T; Meng MM; Bao L; Chen SB; Liu FQ; Wang L
    Sci Rep; 2023 Sep; 13(1):15244. PubMed ID: 37709823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
    Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
    Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).
    Routhu M; Safka V; Routhu SK; Fejfar T; Jirkovsky V; Krajina A; Cermakova E; Hosak L; Hulek P
    Ann Hepatol; 2017; 16(1):140-148. PubMed ID: 28051803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.